Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Basílio de Bragança Pereira is active.

Publication


Featured researches published by Basílio de Bragança Pereira.


Annals of Operations Research | 2010

Evaluating the performance of Brazilian university hospitals

Yasar A. Ozcan; Marcos Pereira Estellita Lins; Maria Stella de Castro Lobo; Angela Cristina Moreira da Silva; Roberto Fiszman; Basílio de Bragança Pereira

In order to demonstrate how DEA modeling can be helpful to aid decision making relative to the Brazilian Teaching Hospital Policy by means of hospital performance assessment, we develop a case study with 30 general hospitals linked to Brazilian Federal Universities. We consider data on medical care (Medical Model—MM), teaching and research (Teaching-Research Model—TRM) and use the software IDEAL (Interactive Data Envelopment Analysis Laboratory) as a tool for the units’ efficiency evaluation. IDEAL, developed in Brazil, is unique in providing a 3-D frontiers visualization, assisting in exploratory analysis and allowing a better understanding of the DEA modeling (envelopment and multiplier). Both models are input-oriented and each hospital is categorized according to its relative efficiency in the MM and TRM. In this phase, it is very important to discuss with the decision-makers the results and patterns of the DEA models. Finally, the modelling indicates the necessary changes for the inefficient units and generates recommendations for teaching ratios and public financing.


Journal of Hypertension | 2013

Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study.

Gil F. Salles; Nathalie C. Leite; Basílio de Bragança Pereira; Emilia Matos do Nascimento; Claudia R.L. Cardoso

Background: The prognostic importance of tight clinic blood pressure (BP) control is controversial in diabetic patients. The objective was to investigate the prognostic impact of clinic and ambulatory BPs for cardiovascular morbidity and mortality in type 2 diabetes. Methods: In a prospective cohort study, 565 type 2 diabetic patients had clinical, laboratory and ambulatory BP monitoring (ABPM) data obtained at baseline and during follow-up. The primary endpoints were a composite of fatal and nonfatal cardiovascular events and all-cause mortality. Multivariable Cox survival and splines regression analyses assessed associations between each BP component [SBP, DBP and pulse pressure (PP)] and the endpoints. Results: After a median follow-up of 5.75 years, 88 total cardiovascular events and 70 all-cause deaths occurred. After adjustments for cardiovascular risk factors, clinic SBP and DBPs were predictive of the composite endpoint but not of all-cause mortality, whereas all ambulatory BP components were predictors of both endpoints. Ambulatory systolic and PPs were the strongest predictors and achieved ambulatory BPs during follow-up improved risk prediction in relation to baseline values. When categorized at clinically relevant cut-off values, risk began only at clinic BPs at least 140/90 mmHg, whereas for ambulatory BPs it began at lower values (≥120/75 mmHg for the 24-h period). Conclusion: ABPM provides more valuable information regarding cardiovascular risk stratification than office BPs and should be performed, if possible, in every high-risk type 2 diabetic patient. Achieved 24-h ambulatory BPs less than 120/75 mmHg are associated with significant cardiovascular protection and, if confirmed by other studies, may be considered as BP treatment targets.


Archive | 2007

Neural Networks: An Application for Predicting Smear Negative Pulmonary Tuberculosis

Alcione Miranda dos Santos; Basílio de Bragança Pereira; José Seixas; Fernanda Carvalho de Queiroz Mello; Afrânio Lineu Kritski

Smear negative pulmonary tuberculosis (SNPT) accounts for 30% of pulmonary tuberculosis (PT) cases reported yearly. Rapid and accurate diagnosis of SNPT could provide lower morbidity and mortality, and case detection at a less contagious status. The main objective of this work is to evaluate a prediction model for diagnosis of SNPT, useful for outpatients who are attended in settings with limited resources. The data used for developing the proposed models werecomprised of 136 patients from health care units. They were referred to the University Hospital in Rio de Janeiro, Brazil, from March 2001 to September 2002, with clinical-radiological suspicion of SNPT. Only symptoms and physical signs were used for constructing the neural network (NN) modelling, which was able to correctly classify 77% of patients from a test sample. The achievements of the NN model suggest that mathematical modelling, developed for classifying SNPT cases could be a useful tool for optimizing application of more expensive tests, and to avoid costs of unnecessary anti-PT treatment. In addition, the main features extracted by the neural model are shown to agree with current analysis from experts in the field.


Clinics | 2009

Sequential allocation to balance prognostic factors in a psychiatric clinical trial

Victor Fossaluza; Juliana Belo Diniz; Basílio de Bragança Pereira; Euripedes C. Miguel; Carlos Alberto Pereira

OBJECTIVE: This paper aims to describe and discuss a minimization procedure specifically designed for a clinical trial that evaluates treatment efficacy for OCD patients. METHOD: Aitchison’s compositional distance was used to calculate vectors for each possibility of allocation in a covariate adaptive method. Two different procedures were designed to allocate patients in small blocks or sequentially one-by-one. RESULTS: We present partial results of this allocation procedure as well as simulated data. In the clinical trial for which this procedure was developed, successful balancing between treatment arms was achieved. Separately, in an exploratory analysis, we found that if the arrival order of patients was altered, most patients were allocated to a different treatment arm than their original assignment. CONCLUSION: Our results show that the random arrival order of patients determine different assignments and therefore maintains the unpredictability of the allocation method. We conclude that our proposed procedure allows for the use of a large number of prognostic factors in a given allocation decision. Our method seems adequate for the design of the psychiatric trials used as models. Trial registrations are available at clinicaltrials.gov NCT00466609 and NCT00680602.


Revista Da Sociedade Brasileira De Medicina Tropical | 2007

Pacientes chagásicos crônicos portadores de disfunção do nódulo sinusal: a presença de anticorpos IgG com ação agonista muscarínica independe da disfunção ventricular esquerda?

Maria Beatriz Corrêa de Mello Altschüller; Roberto Coury Pedrosa; Basílio de Bragança Pereira; Wilson Braz Corrêa Filho; Aline Silva de Medeiros; Patricia C. Costa; Antonio Carlos Campos de Carvalho

Studies have shown that muscarinic agonist IgG antibodies from Chagas disease patients alter the electrical activity of cardiac cells in vitro. Others have considered their presence, along with sinus node dysfunction, to be consequences of progressive cardiac lesions. The aim of this study was to evaluate the relationship between these antibodies and sinus node and left ventricular dysfunction in 65 chronic Chagas disease patients. These patients were divided into group I, composed of 31 patients with sinus node dysfunction, and group II, composed of the patients without this syndrome. Data analysis using the log linear model showed interdependence between sinus node dysfunction and the antibodies (p = 0.0021) and between nodal and ventricular dysfunction (p = 0.0005). However, no relationship was found between the antibodies and ventricular function. Age and sex did not influence any other variables. The chronic Chagas disease patients with sinus node dysfunction had higher prevalence of muscarinic agonist antibodies, independent of the presence of myocardial dysfunction.


Revista De Psiquiatria Clinica | 2003

Validação transcultural da Escala de Avaliação de Limitações no Comportamento Social - SBS-BR

Lúcia Abelha Lima; Sylvia Gonçalves; Giovanni Lovisi; Basílio de Bragança Pereira

Este trabalho apresenta os resultados referentes a validacao da versao brasileira daSocial Behaviour Schedule - SBS, escala que avalia as limitacoes no comportamento social de pacientes psiquiatricos. O estudo de traducao e adaptacao transcultural do instrumento foi realizado pelo Nucleo de Pesquisa do Instituto Municipal de Assistencia a Saude Juliano Moreira (IMASJM), RJ, e a coleta de dados foi feita nas Unidades Assistenciais do IMASJM. Analise das propriedades psicometricas da escala foi feita no Nucleo de Ensino e Saude Coletiva (NESC) da UFRJ. A Escala de Avaliacao do Comportamento Social foi submetida a uma backtranslation, assim como a um estudo piloto sendo avaliada por uma comissao de especialistas, para que fosse feita sua adaptacao ao nosso contexto. A SBS-BR mostrou-se uma escala com qualidades psicometricas de validade e fidedignidade satisfatorias, no que se refere a consistencia interna da escala, bem como a sua validade discriminante e de construto. A analise da estrutura fatorial da escala nos permitiu a identificacao de quatro sindromes comportamentais bem definidas. Estudos futuros deverao aprofundar a investigacao das qualidades psicometricas da presente escala, no que se refere a sua confiabilidade com relacao a interentrevistados e interentrevistadores. A Escala SBS-BR tem muito a contribuir na avaliacao do impacto dos novos programas de saude mental, principalmente no que diz respeito aos pacientes psiquiatricos com disturbios severos e persistentes.


Cerebrovascular Diseases | 2013

Is Poststroke Depression a Major Depression

Carlos Eduardo da Rocha e Silva; Marco Antonio Alves Brasil; Emilia Matos do Nascimento; Basílio de Bragança Pereira; Charles André

Background: Poststroke depression (PSD) is the most common neuropsychiatric consequence of stroke. A large number of studies have focused on the pathogenesis of PSD, but only a few aimed to characterize its psychopathology; these studies yielded results that are difficult to compare because of the different methods utilized. The current study aimed to characterize the symptom profile of PSD in an attempt to better understand the disease and allow a more accurate diagnosis. Methods: The study sample comprised 64 patients divided into three groups: stroke patients without diagnosis of depression (n = 33), stroke patients diagnosed with PSD (PSD group, n = 14) and patients diagnosed with major depression (MD) but with no clinical comorbidity (MD group, n = 17). All patients were diagnosed using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). The initial diagnostic interview was complemented by the Mini Mental State Examination (MMSE), the Rankin Scale, and four scales for the assessment of the intensity of symptoms of anxiety and depression: the Beck Depression Inventory (BDI), the Hospital Anxiety and Depression General Scale (HADS), the Hamilton Depression Rating Scale (HAM-D) and the Hamilton Rating Scale for Anxiety (HAM-A). The Star Plot, a graphical method of data visualization, was used to analyze the results. The t test was used for independent samples (two-tailed analysis). Results: As measured by the BDI, HAM-D and HAM-A scales and HADS depression subscale, the average total scores of symptoms for the sample of patients diagnosed with MD without clinical comorbidity was significantly higher than that of the PSD patients (p < 0.05). Similar results were obtained by plotting the BDI data on Star Plot. The PSD patients showed mild typical depressive symptoms such as less depressed mood, anhedonia, disinterest, guilt, negative thoughts, depreciation, suicidal ideation and anxiety, when evaluated by the HAM-A scale. Moreover, the somatic symptoms of depression did not lead to increased diagnosis of major depression in stroke patients. Conclusions: The results indicate that the PSD clinical picture comprised, in general, symptoms of mild/moderate intensity, especially those considered as pillars for the diagnosis of depression: depressed mood, loss of pleasure and lack of interest. Given the imprecision of boundaries that separate the clinical forms of depression from subclinical and nonpathological forms, or even from the concepts of demoralization and adjustment disorders, we situate PSD in a complex biopsychosocial context in which a better understanding of its psychopathological profile could provide diagnostic and therapeutic alternatives best suited to the difficult reality experienced by stroke patients.


Arquivos Brasileiros De Cardiologia | 2014

Relationship between Fibrosis and Ventricular Arrhythmias in Chagas Heart Disease Without Ventricular Dysfunction

Eduardo Marinho Tassi; Marcelo Abramoff Continentino; Emilia Matos do Nascimento; Basílio de Bragança Pereira; Roberto Coury Pedrosa

Background Patients with Chagas disease and segmental wall motion abnormality (SWMA) have worse prognosis independent of left ventricular ejection fraction (LVEF). Cardiac magnetic resonance (CMR) is currently the best method to detect SWMA and to assess fibrosis. Objective To quantify fibrosis by using late gadolinium enhancement CMR in patients with Chagas disease and preserved or minimally impaired ventricular function (> 45%), and to detect patterns of dependence between fibrosis, SWMA and LVEF in the presence of ventricular arrhythmia. Methods Electrocardiogram, treadmill exercise test, Holter and CMR were carried out in 61 patients, who were divided into three groups as follows: (1) normal electrocardiogram and CMR without SWMA; (2) abnormal electrocardiogram and CMR without SWMA; (3) CMR with SWMA independently of electrocardiogram. Results The number of patients with ventricular arrhythmia in relation to the total of patients, the percentage of fibrosis, and the LVEF were, respectively: Group 1, 4/26, 0.74% and 74.34%; Group 2, 4/16, 3.96% and 68.5%; and Group 3, 11/19, 14.07% and 55.59%. Ventricular arrhythmia was found in 31.1% of the patients. Those with and without ventricular arrhythmia had mean LVEF of 59.87% and 70.18%, respectively, and fibrosis percentage of 11.03% and 3.01%, respectively. Of the variables SWMA, groups, age, LVEF and fibrosis, only the latter was significant for the presence of ventricular arrhythmia, with a cutoff point of 11.78% for fibrosis mass (p < 0.001). Conclusion Even in patients with Chagas disease and preserved or minimally impaired ventricular function, electrical instability can be present. Regarding the presence of ventricular arrhythmia, fibrosis is the most important variable, its amount being proportional to the complexity of the groups.


Revista Brasileira De Epidemiologia | 2005

Usando redes neurais artificiais e regressão logística na predição da Hepatite A

Alcione Miranda dos Santos; José Seixas; Basílio de Bragança Pereira; Roberto de Andrade Medronho

Este trabalho desenvolve um sistema para predicao da soroprevalencia da Hepatite A. Para isto, sao considerados os modelos de regressao de logistica e redes neurais artificiais. O desempenho de tais modelos e medido atraves da taxa de classificacao incorreta em uma amostra do municipio de Duque de Caxias, Rio de Janeiro, que possui elevada prevalencia da doenca. Resultados mostram que o modelo neural, aplicado sobre a informacao relevante extraida do modelo de regressao logistica, apresenta um bom desempenho, alcancando uma eficiencia de classificacao geral acima de 88%.


Arquivos Brasileiros De Endocrinologia E Metabologia | 2005

Triagem neonatal para hiperplasia adrenal congênita: experiência do estado do Rio de Janeiro

Cláudia B.M.A. Cardoso; Armando A. Fonseca; Maria de Fátima S. Oliveira; Basílio de Bragança Pereira; Marília M. Guimarães

OBJECTIVE To determine the 17OH progesterone (17OHP) levels in the neonatal screening for Congenital Adrenal Hyperplasia due to 21 hydroxylase deficiency (CAH-21OHD). CASUISTIC AND METHOD The evaluation was performed using 76,360 paper filter samples, obtained from newborn screening in Rio de Janeiro from June 1992 to December 2000. The 17OHP were assayed by fluoroimmunoassay method using the blood collected onto filter paper cards. The cut-off level was 10 ng/mL. The infants with 17OHP levels above this cut-off were recalled to undergo a new dosage. RESULTS Thirty-eight patients presented 17OHP levels above the cut-off limit. In 11 (4 males, 6 females, 1 undefined gender) the diagnoses of CAH-21OHD were confirmed. Their 17OHP levels ranged from 25 to 254.5 ng/mL (mean: 133.84 ng/mL) on the first analysis and from 46.86 to 360 ng/mL (mean: 218.84 ng/mL) on the second analysis. The patients with the salt-wasting form showed higher 17OHP levels when compared to simple virilizers, both on the first analysis (mean: 169.21 ng/mL vs 27.46 ng/mL) and on the second one (mean: 227.16 ng/mL vs 110.95 ng/mL). Among the 27 infants without confirmed disease (false-positives), 17OHP levels ranged from 10.27 to 27.5 ng/mL (mean: 14.8 ng/mL) on the first sample and from 2.39 to 32.39 ng/mL (mean: 10.07 ng/mL) on the second. In this group, 8 children maintained borderline 17OHP levels during a variable period, but in 7 of them it was normalized before the first year of life. In the remaining case, who was asymptomatic after 8 years of follow-up, a cortrosin stimulation test was compatible with the non-classic form of the disease. CONCLUSION These data confirm that 17OHP analysis was a reliable test to CAH-21OHD neonatal screening and was able to differentiate between normal infants and those with the classical form of CAH-21OHD.

Collaboration


Dive into the Basílio de Bragança Pereira's collaboration.

Top Co-Authors

Avatar

Emilia Matos do Nascimento

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Roberto Coury Pedrosa

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Clarissa Antunes Thiers

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

José Seixas

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

João Luis Barbosa

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Mauro Alves

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Paulo Henrique Godoy

Federal University of Rio de Janeiro

View shared research outputs
Researchain Logo
Decentralizing Knowledge